Filter Results:
(1,162)
Show Results For
- All HBS Web
(1,162)
- People (13)
- News (524)
- Research (501)
- Multimedia (4)
- Faculty Publications (76)
Show Results For
- All HBS Web
(1,162)
- People (13)
- News (524)
- Research (501)
- Multimedia (4)
- Faculty Publications (76)
Samantha Smith
Samantha is a behavioral scientist, earning her Ph.D. in Organizational Behavior (Micro) at Harvard Business School. Her research examines employees' strategic decisions under competition. Her work also examines how to harness diverse talent effectively, driving... View Details
- 25 Aug 2010
- News
From CIA to BIA: Spotting execs who bend the truth
- 06 Nov 2012
- First Look
First Look: November 6
conference calls show less trading volume and price movement following the information releases, after controlling for the actual earnings news. Further, the capital market's... View Details
Keywords: Sean Silverthorne
- 29 Nov 2017
- Blog Post
HBS, A Dream and Trey: How HBS Helped Me Launch My Social Enterprise
"Nice talking to you as well!" I hung up the phone and looked out the window of my company's conference room, high above midtown Manhattan. I had just finished a call regarding my acceptance to HBS... View Details
- 2014
- Working Paper
Linguistic Complexity in Firm Disclosures: Obfuscation or Information?
By: Brian J. Bushee, Ian D. Gow and Daniel Taylor
Prior research argues that the linguistic complexity of a firm’s disclosures reflects managerial obfuscation. However, complex language can be used either to obfuscate or to convey information, with the effect likely depending on the incentives of the source. We... View Details
- 24 Mar 2002
- Research & Ideas
The Trick of Balancing Business and Government
Asked which institutions must be in place in order for African countries to grow, experts on a panel at the Africa Business Conference had no shortage of suggestions. One panelist, representing the International Monetary Fund, voted for a... View Details
Keywords: by Martha Lagace
- 20 Nov 2015
- News
Insurance giant shakes ACA tree
- 26 Jan 2011
- News
China, South Africa Advance Sustainability Efforts
- 13 Feb 2012
- News
The horizon vocabulary
- March 2011
- Article
Do Sell-Side Stock Analysts Exhibit Escalation of Commitment?
By: John Beshears and Katherine L. Milkman
This paper presents evidence that when an analyst makes an out-of-consensus forecast of a company's quarterly earnings that turns out to be incorrect, she escalates her commitment to maintaining an out-of-consensus view on the company. Relative to an analyst who was... View Details
Keywords: Escalation Of Commitment; Stock Market; Updating; Behavioral Economics; Motivation and Incentives; Behavior; Consumer Behavior; Financial Markets; Forecasting and Prediction
Beshears, John, and Katherine L. Milkman. "Do Sell-Side Stock Analysts Exhibit Escalation of Commitment?" Journal of Economic Behavior & Organization 77, no. 3 (March 2011): 304–317.
- 29 Sep 2014
- News
The Facebook gambit
- January 2013 (Revised August 2013)
- Case
First Solar: CFRA's Accounting Quality Concerns
By: Suraj Srinivasan and Ian McKown Cornell
The case relates to accounting quality analysis conducted by the leading research firm Center for Financial Research and Analysis (CFRA) on companies in the solar industry with a focus on First Solar Inc. In 2009, CFRA was concerned that First Solar, like much of the... View Details
Keywords: Accounting; Accounting Quality; Financial Accounting; Financial Statement Analysis; Accounting Fraud; Accounting Red Flags; Accounting Scandal; Risk and Uncertainty; Quality; Earnings Management; Valuation; Crime and Corruption; Financial Statements; Energy Sources; Green Technology Industry; Accounting Industry; Energy Industry
Srinivasan, Suraj, and Ian McKown Cornell. "First Solar: CFRA's Accounting Quality Concerns." Harvard Business School Case 113-044, January 2013. (Revised August 2013.)
- 08 Nov 2016
- Working Paper Summaries
Managers' Cultural Background and Disclosure Attributes
- November 2018 (Revised January 2019)
- Case
Investor Relations Practices at Edwards Lifesciences
By: C. Fritz Foley and F. Katelynn Boland
In January 2017, the senior leadership team at Edwards Lifesciences were preparing for the quarterly earnings call that would cover the fourth quarter of 2016. They faced questions about what types of information they should disclose on the call, as well as during... View Details
Keywords: Investor Relations; Medical Devices; Corporate Disclosure; Decisions; Business and Shareholder Relations; Medical Devices and Supplies Industry; United States
Foley, C. Fritz, and F. Katelynn Boland. "Investor Relations Practices at Edwards Lifesciences." Harvard Business School Case 219-058, November 2018. (Revised January 2019.)
- 15 Oct 2012
- News
Pay-as-You-Drive Insurance: Big Brother Needs a Makeover
- June 18, 2019
- Article
Research: Investors Reward Companies That Talk Up Their Digital Initiatives
By: Suraj Srinivasan and Wilbur Chen
A study of how companies disclose their digital initiatives on earnings calls and written communications finds that more firms are using these technologies, that financial markets reward companies that disclose such initiatives, but that financial performance... View Details
Srinivasan, Suraj, and Wilbur Chen. "Research: Investors Reward Companies That Talk Up Their Digital Initiatives." Harvard Business Review (website) (June 18, 2019).
Lumumba B. Seegars
Lumumba Seegars is an Assistant Professor of Business Administration in the Organizational Behavior Unit at Harvard Business School. He teaches the Leadership and Organizational Behavior course (LEAD) in the MBA Required Curriculum.
Professor Seegars... View Details
- October 2019
- Supplement
Impax Laboratories: Executing Accretive Transactions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
- October 2019
- Case
Impax Laboratories: Executing Accretive Acquisitions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (A)." Harvard Business School Case 220-030, October 2019.